UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

FEATURES OF IMMUNOLOGICAL REACTIVITY OF PATIENTS WITH COMBAT TRAUMATIC BRAIN INJURY DEPENDING ON ITS TYPE AND CHRONICIT

Type of Article

In the Section

Index UDK:

Abstract

Among modern studies of the participation of the immune system in the pathogenesis of traumatic brain injury (TBI) in military — veterans and combatants — the study of immunological mechanisms in the most acute and acute periods, which include the first hours, days and weeks after receiving combat TBI, prevails. In this regard, it is of particular relevance to determine the features of immuno-logical reactivity due to traumatization of the nervous system in terms of the chronicity of the course of mild TBI, also taking into account the high motivation of combatants to return to the battlefield, which contributes to their ability to minimize the severity of neuropsychiatric symptoms. All this dictates the need to create effective clinical recommendations to prevent complications of mild TBI based on objective indicators, rather than subjective sensations. The aim of the work was a comparative analysis of the indicators of the humoral link of immunological reactivity, natural nonspecific resistance of the organism and the central and peripheral representation of pro- and anti-inflammatory mediators of the immune system in patients with combat TBI in the aspect of its chronic course. As a result of the generalization of the obtained data, signs of neuroinflammation were noted in the acute period (1.22±0.19 months), which persist in combatants in the intermediate (6.39±0.74 months) and remote (13.43±1.13 months) periods, which may be the basis for the development of complications with further aggravation of neuropsychiatric deficit.

Pages

References

  1. Rodney T, Taylor P, Dunbar K, et al. High IL-6 in military personnel relates to multiple traumatic brain injuries and posttraumatic stress disorder. Behav Brain Res. 2020;392:112715. doi: https://doi.org/10.1016/j.bbr.2020.112715.
  2. Kim HJ, Tsao JW, Stanfill AG. The current state of biomarkers of mild traumatic brain injury. JCI Insight. 2018;3(1):e97105. doi:10.1172/jci.insight.97105.
  3. Edwards KA, Gill JM, Pattinson CL, et al. Interleukin-6 is associated with acute concussion in military combat personnel. BMC Neurology. 2020;20(1):209. Published 2020 May 25. doi: https://doi.org/10.1186/s12883-020-01760-x.
  4. Tsitsipanis C, Miliaraki M, Paflioti E, et al. Inflammation biomarkers IL-6 and IL-10 may improve the diagnostic and prognostic accuracy of currently authorized traumatic brain injury tools. Exp Ther Med. 2023;26(2):364. Published 2023 Jun 12. doi: https://doi.org/10.3892/etm.2023.12063.
  5. Korovka S. Y. Mechanisms of formation of endogenous intoxication syndrome in traumatic brain injury: PhD thesis for the degree of Candidate of Medical Sciences: specialty 14.03.04 "Pathological physiology". Donetsk, 2013. 20 с. Korovka S. Ya. Mechanisms of formation of the syndrome of endogenous intoxication in traumatic brain injury [dissertation]. Donetsk, 2013. 20 p. (In Ukrainian).
  6. Zyablitsev S.V. Mechanisms of inflammatory and autoimmune reactions in traumatic brain injury / S.V. Zyablitsev, Y.S. Yuzkiv // Achievements of Clinical and Experimental Medicine. 2016. № 3. С. 34-38. Ziablitsev S. V., Yuzʹkiv Ya. S. Mechanisms of inflammatory and autoimmune reactions in traumatic brain injury. Achievements of clinical and experimental medicine [Achievements of clinical and experimental medicine]. 2016;3:34-38.
  7. McKee CA, Lukens JR. Emerging roles for the immune system in traumatic brain injury. Frontiers in Immunology. 2016;7:556. doi:https://doi.org/10.3389/fimmu.2016.00556.
  8. Johnson VE, Stewart JE, Begbie FD, et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013 Jan;136(Pt 1):28-42. doi:https://doi.org/10.1093/brain/aws322.
  9. Ramlackhansingh A., Brooks D., Greenwood R., Bose S., Turkheimer F., Kinnunen K., et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011. 70 (3). P. 374–383. doi:https://doi.org/10.1002/ana.22455.
  10. Russo MV, McGavern DB. Inflammatory neuroprotection following traumatic brain injury. Science. 2016;353(6301):783-5. doi:https://doi.org/10.1126/science.aaf6260.
  11. Nizamutdinov D, Shapiro LA. Overview of Traumatic Brain Injury: An Immunological Context. Brain Sci. 2017;7(1):11. doi:https://doi.org/10.3390/brainsci7010011.
  12. Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29(8):357-365. doi:https://doi.org/10.1016/j.it.2008.05.002.
  13. Bouras M, Asehnoune K, Roquilly A. Immune modulation after traumatic brain injury. Front Med (Lausanne). 2022;9:995044. doi:https://doi.org/10.3389/fmed.2022.995044.
  14. Blennow K, Hardy J, Zetterberg H. The neuropathology and neurobiology of traumatic brain injury. Neuron. 2012;76(5):886-99. doi:https://doi.org/10.1016/j.neuron.2012.11.021.
  15. Tsymbaliuk V. I., Posokhov M. F., Suprun E. V. Mild traumatic brain injuries associated with combat operations: current features // Ukrainian Journal of Psychoneurology. 2023. Vol. 31, No. 3 (116). С. 5-11. Tsymbaliuk V. I., Posokhov M. F., Suprun E. V. Mild traumatic brain injuries associated with combat operations: current features. Ukrainskyi visnyk psykhonevrolohii [Ukrainian Bulletin of Psychoneurology]. 2023. 31, 3 (116). P. 5-11. doi:https://doi.org/10.36927/2079-0325-V31-is3-2023-1. (In Ukrainian).
  16. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol. 1999;101(2):211-21. doi:https://doi.org/10.1016/s0165-5728(99)00148-4.